Article | January 17, 2025

What Does 2025 Hold For Pharma?

Source: Citeline

By Darcy Grabenstein

GettyImages-2170642314-year 2025

In 2025, the pharmaceutical industry is expected to undergo transformative changes influenced by advancements in technology and evolving regulatory landscapes. A significant trend will be the integration of Artificial Intelligence (AI) in drug discovery and personalized medicine, with a focus on establishing regulatory frameworks to mitigate associated risks. The FDA's anticipated guidance on enhancing diversity in clinical trials will mandate sponsors to set specific demographic goals, promoting inclusivity for underrepresented groups. Additionally, Europe is expected to lead in clinical trial transparency, with new regulations shaping disclosure practices.

Citeline's Thomas Wicks predicts a rise in demand for plain language summaries and improved data anonymization for GDPR compliance. Meanwhile, the APAC region will witness a surge in drug innovation, particularly in China, alongside evolving regulatory environments in Japan and India. The weight-loss drug market, especially for GLP-1 drugs, is projected to grow, while decentralized clinical trials will gain traction, driven by AI and patient-centric strategies. Lastly, emerging research linking COVID-19 to potential cancer treatment strategies may further influence industry directions, necessitating adaptability in this dynamic landscape.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader